Xiao Zhu

7.6k total citations · 3 hit papers
136 papers, 5.5k citations indexed

About

Xiao Zhu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiao Zhu has authored 136 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 48 papers in Cancer Research and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiao Zhu's work include RNA modifications and cancer (35 papers), Cancer-related molecular mechanisms research (27 papers) and Ferroptosis and cancer prognosis (17 papers). Xiao Zhu is often cited by papers focused on RNA modifications and cancer (35 papers), Cancer-related molecular mechanisms research (27 papers) and Ferroptosis and cancer prognosis (17 papers). Xiao Zhu collaborates with scholars based in China, United States and Hong Kong. Xiao Zhu's co-authors include Dongpei Li, Hui Luo, Tao Tao, Hongmei Li, Shuzhen Tan, Zhilin Zou, Lianfang Huang, Haiqing Luo, Wenguo Fan and Kai Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Xiao Zhu

130 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

2020 662 citations Zhilin Zou, Tao Tao et al. profile →
Cancer immunotherapy: Pros, cons and beyond

2020 501 citations Shuzhen Tan, Xiao Zhu et al. Biomedicine & Pharmacotherapy profile →
Microsatellite instability: a review of what the oncologist should know

2020 337 citations Lianfang Huang, Hui Luo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiao Zhu China	39	3.1k	1.7k	1.2k	759	683	136	5.5k
Ying Zhang China	40	3.5k 1.1×	1.2k 0.7×	1.8k 1.5×	637 0.8×	578 0.8×	258	6.2k
Xiaoling Li China	45	3.6k 1.2×	1.8k 1.1×	1.4k 1.2×	1.3k 1.7×	1.1k 1.6×	224	6.9k
Gopal C. Kundu India	50	3.6k 1.2×	1.5k 0.9×	1.5k 1.3×	877 1.2×	598 0.9×	134	7.3k
Seema Singh United States	43	3.1k 1.0×	1.8k 1.1×	1.4k 1.2×	724 1.0×	380 0.6×	126	5.1k
Ke Cao China	34	2.9k 0.9×	1.9k 1.2×	1.2k 1.0×	761 1.0×	1.0k 1.5×	151	5.3k
Tong Chen China	35	3.1k 1.0×	1.4k 0.8×	737 0.6×	538 0.7×	433 0.6×	218	5.2k
Qing Xu China	32	2.0k 0.6×	1.0k 0.6×	1.5k 1.2×	556 0.7×	876 1.3×	182	4.3k
Jiang Li China	41	2.7k 0.9×	1.6k 1.0×	1.6k 1.3×	1.5k 2.0×	550 0.8×	213	5.6k
Tao Ning China	33	2.5k 0.8×	1.6k 1.0×	835 0.7×	580 0.8×	693 1.0×	151	4.4k
Aimin Li China	38	2.6k 0.8×	890 0.5×	879 0.7×	553 0.7×	667 1.0×	220	5.1k

Countries citing papers authored by Xiao Zhu

Since Specialization

Citations

This map shows the geographic impact of Xiao Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Zhu more than expected).

Fields of papers citing papers by Xiao Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Zhu. The network helps show where Xiao Zhu may publish in the future.

Co-authorship network of co-authors of Xiao Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Zhu. A scholar is included among the top collaborators of Xiao Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Zhu. Xiao Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Rui, et al.. (2025). GalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases. Expert Opinion on Drug Delivery. 22(4). 455–469. 11 indexed citations

Liu, Kai, Hui Zeng, Xiao Zhu, et al.. (2025). Shenling Tongqiao powder targets TGF-β1/Smad-Wnt/β-catenin axis to suppress epithelial-mesenchymal transition in chronic rhinosinusitis. Phytomedicine. 145. 157065–157065.

Zhu, Xiao, et al.. (2025). Analysis of zebrafish homologs within the human genome provides valuable insights into exploring pan-cancer alternative splicing events as prognostic markers and therapeutic targets. SHILAP Revista de lepidopterología. 14. 100046–100046.

Zhu, Xiao, et al.. (2024). The intricate dance of tumor evolution: Exploring immune escape, tumor migration, drug resistance, and treatment strategies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167098–167098. 2 indexed citations

Li, Hui, et al.. (2024). Graphene therapy-related lncRNAs as prognostic and immune microenvironmental biomarkers in hepatocellular carcinoma. Translational Oncology. 43. 101915–101915. 5 indexed citations

Yin, Fei, et al.. (2024). Combination of transcriptome and Mendelian inheritance reveals novel prognostic biomarker of CTLA-4-related lncRNAs and protective role of nitrogen metabolism pathway in lung adenocarcinoma development. BMC Cancer. 24(1). 1009–1009. 4 indexed citations

Chen, Xiurong, et al.. (2024). Mining phase separation-related diagnostic biomarkers for endometriosis through WGCNA and multiple machine learning techniques: a retrospective and nomogram study. Journal of Assisted Reproduction and Genetics. 41(5). 1433–1447. 1 indexed citations

Li, Wei, Xiao Zhu, Wei Su, et al.. (2024). Safety, immunogenicity, and preliminary efficacy of a randomized clinical trial of omicron XBB.1.5-containing bivalent mRNA vaccine. 2(3). 113–125. 2 indexed citations

Tao, Tao, Jiaao Yu, Ziyu Liu, et al.. (2023). A ferroptosis‐related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study. Cancer Reports. 7(1). e1925–e1925. 4 indexed citations

10.

Liu, Ziyu, Zhihong Chen, Shuhong Wu, et al.. (2023). Why Treg should be the focus of cancer immunotherapy: The latest thought. Biomedicine & Pharmacotherapy. 168. 115142–115142. 21 indexed citations

11.

Li, Jinhong, Junhua Wang, Zhihong Chen, et al.. (2023). An Exosome-Related Long Non-coding RNA (lncRNA)-Based Signature for Prognosis and Therapeutic Interventions in Lung Adenocarcinoma. Cureus. 15(10). e47574–e47574. 6 indexed citations

12.

Zhang, Ming, et al.. (2023). Computational identification of long non-coding RNAs associated with graphene therapy in glioblastoma multiforme. Brain Communications. 6(1). fcad293–fcad293. 2 indexed citations

13.

Zou, Zhilin, Shu‐Guang Zhou, Guosheng Liang, et al.. (2021). The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators. Molecular Omics. 17(3). 438–453. 21 indexed citations

14.

Zou, Zhilin, Shu‐Guang Zhou, Guosheng Liang, et al.. (2021). Correction: The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators. Molecular Omics. 17(4). 641–641. 1 indexed citations

15.

Huang, Lianfang, et al.. (2020). Bone metabolism regulation: Implications for the treatment of bone diseases. Biomedicine & Pharmacotherapy. 129. 110494–110494. 28 indexed citations

16.

Kong, Ying, Wenguo Fan, Tao Tao, et al.. (2020). Principles of RNA methylation and their implications for biology and medicine. Biomedicine & Pharmacotherapy. 131. 110731–110731. 97 indexed citations

17.

Xu, Zhenhua, et al.. (2020). New insights into molecules and pathways of cancer metabolism and therapeutic implications. Cancer Communications. 41(1). 16–36. 71 indexed citations

18.

Liu, Zhen, Binhua Wu, Xiaoning Tang, et al.. (2020). Imaging genomics for accurate diagnosis and treatment of tumors: A cutting edge overview. Biomedicine & Pharmacotherapy. 135. 111173–111173. 11 indexed citations

19.

Huang, Yike, Junchi He, Huaping Liang, et al.. (2018). Aryl Hydrocarbon Receptor Regulates Apoptosis and Inflammation in a Murine Model of Experimental Autoimmune Uveitis. Frontiers in Immunology. 9. 1713–1713. 62 indexed citations

20.

Zhang, Jin-fang, Hua Wang, Hongsheng Tan, et al.. (2012). Apoptosis induced by 1,3,6,7-tetrahydroxyxanthone in Hepatocellular carcinoma and proteomic analysis. APOPTOSIS. 17(8). 842–851. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact